Cochrane review of using Pralidoxime for organophosphate toxicity reveals insufficient evidence for or against its use. WHO recommended dose in RCT trended towards patient harm in all subgroups. Overall quality of evidence is poor. https://t.co/yD4T8S42Sn
1,391 followers
2,020 followers
RT @EM_vlee: Graudins: High dose pralidoxime for OP tox may not be useful https://t.co/fCOZPW4JhZ #acemvic16
1,546 followers
RT @EM_vlee: Graudins: High dose pralidoxime for OP tox may not be useful https://t.co/fCOZPW4JhZ #acemvic16
708 followers
Graudins: High dose pralidoxime for OP tox may not be useful https://t.co/fCOZPW4JhZ #acemvic16